Essential Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.8K Buy
2,086
+22
+1% +$241 0.01% 865
2026
Q2
$18.9K Buy
2,064
+757
+58% +$8.45K 0.01% 933
2026
Q1
$14.2K Sell
1,307
-3
-0.2% -$26 ﹤0.01% 1073
2025
Q4
$8K Buy
1,310
+704
+116% +$4.2K ﹤0.01% 1251
2025
Q3
$3.14K Sell
606
-191
-24% -$1.1K ﹤0.01% 1618
2025
Q2
$4.73K Buy
+797
New +$4.8K ﹤0.01% 1069

Other funds holding PTEN

Essential Partners's PTEN Position: Q3 2026 in Review

Essential Partners increased its Patterson-UTI (PTEN) stake by 1.1% in Q3 2026, buying an estimated $241 and bringing the position to 2,086 shares worth $22.8K. The position accounts for 0.01% of the portfolio, ranked #865.

Essential Partners first reported a position in PTEN in Q2 2025 and has held it in 6 quarters since. 30 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • Essential Partners held 2,086 shares of Patterson-UTI worth $22.8K as of Q3 2026.
  • Essential Partners bought 22 Patterson-UTI shares in Q3 2026, an estimated $241.
  • Patterson-UTI made up 0.01% of Essential Partners's portfolio in Q3 2026, its #865 holding.
  • Essential Partners first reported a position in Patterson-UTI in Q2 2025 and has held it in 6 quarters since.
  • 30 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.